Gentherm Incorporated
NASDAQ:THRMAuto - Parts
+$0.43 today
- Market cap
- $1.59B
- Beta
- 1.39
- P/E (TTM)
- 48.9
- EPS (TTM)
- $0.74
Volume 1.03M
Average 0.28M
THRM Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Gentherm IncorporatedNASDAQ: THRM
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development declines year over year
Q1 FY2026 research & development of $23.95M fell 18.8% year over year, behind the -15.1% change in trailing-twelve-month research & development. Sequentially, it rose 1.7% from the prior quarter. Over 3 fiscal years it compounded at +7.7% a year.
Context
- Research & development amounted to 7.2% of revenue in FY2025, down 0.9 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -18.8% toward the trailing-twelve-month pace of -15.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 107.09M USD
- Year-over-year change
- -9.1%
- 4-year CAGR
- +9.2%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 107.09M | -9.1% |
| FY2024 | 2024-12-31 | 117.83M | -6.3% |
| FY2023 | 2023-12-31 | 125.69M | +46.6% |
| FY2022 | 2022-12-31 | 85.72M | +14.0% |
| FY2021 | 2021-12-31 | 75.21M | — |
Research & Development vs competitors
How THRM compares with its peers on the latest reported figures
- THRM's LTM Mar 2026 research & development of $101.53M is the 2nd highest of the 11 companies compared; the peer median is $10.85M.
- Its year-over-year change of -15.1% is the 3rd highest of 8, against a peer median of -63.5%.
- Research & development amounts to 6.6% of revenue for THRM, versus a peer median of 3.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $205.71M | +4.4% | +15.1% | 7.9% | |
| LTM Mar 2026 | $101.53M | -15.1% | +7.7% | 6.6% | |
| LTM Mar 2026 | $60.94M | -63.5% | -17.4% | 12.5% | |
| LTM Mar 2026 | $54.03M | -25.1% | -2.7% | 6.7% | |
| LTM Dec 2025 | $45.06M | +63.0% | +7.7% | 5.9% | |
| LTM Mar 2026 | $21.7M | — | +21.2% | 3.7% | |
| LTM Sep 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Oct 2026 | $0 | -100.0% | +6.6% | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | -31.1% | — | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding THRM) | $10.85M | -63.5% | +6.6% | 3.7% | |
Competitors are the stored peer set for THRM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.05B | 1.2B | 1.47B | 1.46B | 1.49B |
| Cost of Revenue | 742.52M | 931.01M | 1.12B | 1.09B | 1.14B |
| Gross Profit | 303.63M | 273.65M | 351.62M | 366.43M | 351.67M |
| Gross Margin | 29.0% | 22.7% | 23.9% | 25.2% | 23.5% |
| Research & Development | 75.21M | 85.72M | 125.69M | 117.83M | 107.09M |
| Selling, General & Admin | 109.55M | 132.69M | 155.58M | 155.11M | 170.05M |
| Operating Expenses | 188.63M | 225.34M | 274.19M | 259.42M | 273.62M |
| Depreciation & Amortization | 38.78M | 44.39M | 50.95M | 52.98M | 53.26M |
| EBITDA | 157.64M | 99.63M | 152.64M | 175.6M | 102.91M |
| EBITDA Margin | 15.1% | 8.3% | 10.4% | 12.1% | 6.9% |
| Operating Income | 115.01M | 48.31M | 77.44M | 107.02M | 78.05M |
| Operating Margin | 11.0% | 4.0% | 5.3% | 7.3% | 5.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.76M | 4.29M | 14.64M | 15.3M | 13.81M |
| Other Income / Expenses | (1.15M) | (9.93M) | (22.49M) | (4.75M) | (42.22M) |
| Income Before Tax | 113.85M | 38.38M | 54.95M | 102.27M | 35.84M |
| Pre-Tax Margin | 10.9% | 3.2% | 3.7% | 7.0% | 2.4% |
| Income Tax Expense | 20.42M | 13.94M | 14.61M | 37.32M | 17.55M |
| Net Income | 93.43M | 24.44M | 40.34M | 64.95M | 18.29M |
| Net Margin | 8.9% | 2.0% | 2.7% | 4.5% | 1.2% |
| EPS (Basic) | 2.82 | 0.74 | 1.23 | 2.08 | 0.60 |
| EPS (Diluted) | 2.79 | 0.73 | 1.22 | 2.06 | 0.60 |
| Weighted Avg Shares | 33.09M | 33.13M | 32.78M | 31.29M | 30.49M |
| Weighted Avg Shares (Diluted) | 33.51M | 33.5M | 33.07M | 31.48M | 30.94M |
Gentherm Incorporated
NASDAQ:THRM
Intrinsic Alpha fair value
Locked
Current Price
$30.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.